Table 6.
Animal group | Number of ulcers | Percentage incidence of animals | Paul’s index | AA | Severity of inflammation |
---|---|---|---|---|---|
Mean±SD n=6 | |||||
I (normal control) | – | 0 | 0 | – | – (no inflammation) |
II (positive control) | 25±5.67 | 100 | 25 | – | +++ (severe) |
III (diosmin) | 9±3.37* | 66.67 | 6 | 4.16 | ++ (moderate) |
IV (uncoated PLGA nanoparticles) | 4±2*** | 50 | 2 | 12.5 | + (mild) |
V (chitosan-coated nanoparticles) | 2±1.26*** | 33.33 | 0.667 | 37.48 | + (mild) |
Notes: 100 mg/kg diosmin or an equivalent dose of the nanoparticles was used; *P<0.05 and ***P<0.001 vs positive control group (II).
Abbreviations: PLGA, poly(lactic-co-glycolic) acid; AA, anti-ulcer activity.